De Yong Wen
Chief Executive Officer bei SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.
Vermögen: 597 223 $ am 31.03.2024
Profil
De Yong Wen is currently the Co-Chief Executive Officer & Executive Director at Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
He is also the Chairman-Supervisory Board at China National Accord Medicines Corp.
Ltd., a Non-Executive Director at Sinopharm Group Co., Ltd., a Director at China National Medicines Co., Ltd., a Director at Sinopharm Industrial Investment Co., Ltd., and a Non-Executive Director at Shanghai Henlius Biotech, Inc. Previously, Mr. Wen held positions as Vice Chairman at Chongqing Yao Pharmaceutical Co., Ltd.
and Director at C.Q.
Pharmaceutical Holding Co., Ltd.
Mr. Wen obtained an MBA from Donghua University in 2007 and an undergraduate degree from West China University of Medical Sciences in 1995.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 13.12.2022 | 187 100 ( 9,50% ) | 597 223 $ | 31.03.2024 |
Aktive Positionen von De Yong Wen
| Unternehmen | Position | Beginn |
|---|---|---|
| SINOPHARM GROUP CO. LTD. | Director/Board Member | 01.09.2017 |
| CHINA NATIONAL MEDICINES CORPORATION LTD. | Director/Board Member | 09.05.2019 |
| SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. | Chief Executive Officer | 01.06.2022 |
| SHANGHAI HENLIUS BIOTECH, INC. | Director/Board Member | 28.07.2022 |
| CHINA NATIONAL ACCORD MEDICINES CORPORATION LTD. | Chairman | 10.07.2019 |
Sinopharm Industrial Investment Co., Ltd.
 Sinopharm Industrial Investment Co., Ltd. Financial ConglomeratesFinance Sinopharm Industrial Investment Co., Ltd. engages in the provision of industrial investment services. Its business activities include management of pharmaceutical business, asset restructuring and investment advisory services. The company was founded on May 6, 2008 and is headquartered in Shanghai, China. | Director/Board Member | 20.01.2020 |
Ehemalige bekannte Positionen von De Yong Wen
| Unternehmen | Position | Ende |
|---|---|---|
Chongqing Yao Pharmaceutical Co., Ltd.
 Chongqing Yao Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Yao Pharmaceutical Co., Ltd. engages in pharmaceutical manufacture, It integrates with research and development, manufacturing, marketing, and sales of medicines. The company was founded on July 21, 1997 and is headquartered in Chongqing, China. | Director/Board Member | - |
| C.Q. PHARMACEUTICAL HOLDING CO., LTD. | Director/Board Member | - |
Ausbildung von De Yong Wen
| Donghua University | Masters Business Admin |
| West China University of Medical Sciences | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 6 |
|---|---|
| SINOPHARM GROUP CO. LTD. | Distribution Services |
| CHINA NATIONAL ACCORD MEDICINES CORPORATION LTD. | Health Technology |
| SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. | Health Technology |
| CHINA NATIONAL MEDICINES CORPORATION LTD. | Health Technology |
| C.Q. PHARMACEUTICAL HOLDING CO., LTD. | Health Technology |
| SHANGHAI HENLIUS BIOTECH, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Sinopharm Industrial Investment Co., Ltd.
Sinopharm Industrial Investment Co., Ltd. Financial ConglomeratesFinance Sinopharm Industrial Investment Co., Ltd. engages in the provision of industrial investment services. Its business activities include management of pharmaceutical business, asset restructuring and investment advisory services. The company was founded on May 6, 2008 and is headquartered in Shanghai, China. | Finance |
Chongqing Yao Pharmaceutical Co., Ltd.
Chongqing Yao Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Yao Pharmaceutical Co., Ltd. engages in pharmaceutical manufacture, It integrates with research and development, manufacturing, marketing, and sales of medicines. The company was founded on July 21, 1997 and is headquartered in Chongqing, China. | Health Technology |
